Nvidia-Backed Recursion Pharma Soars After-Hours As FDA Eyes AI Over Animal Testing For Drugs

 Shares of Recursion Pharmaceuticals Inc. rocketed over 19% in Thursday's after-hours trading, boosting retail investor sentiment, after the U.S. health regulator unveiled plans to modernize drug testing methodologies.

The U.S. Food and Drug Administration said it would begin replacing traditional animal testing for monoclonal antibody therapies and other drugs with more "human-relevant" methods, including artificial intelligence (AI) models.

https://www.msn.com/en-us/money/markets/nvidia-backed-recursion-pharma-soars-after-hours-as-fda-eyes-ai-over-animal-testing-for-drugs-retail-traders-elated/ar-AA1CIikC